AR020081A1 - Nuevo uso - Google Patents

Nuevo uso

Info

Publication number
AR020081A1
AR020081A1 ARP990102572A ARP990102572A AR020081A1 AR 020081 A1 AR020081 A1 AR 020081A1 AR P990102572 A ARP990102572 A AR P990102572A AR P990102572 A ARP990102572 A AR P990102572A AR 020081 A1 AR020081 A1 AR 020081A1
Authority
AR
Argentina
Prior art keywords
refers
new use
declomethiol
methylthiazole
chloroethyl
Prior art date
Application number
ARP990102572A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR020081A1 publication Critical patent/AR020081A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

La presente se refiere a un nuevo uso medicinal de 5-(2-cloroetil)-4-metiltiazol y las sales y solvatos del mismo farmacéuticamente aceptables y lascomposiciones farmacéuticas que los contienen. En particular, la presente se refiere al uso declometi azol para la prevencion y/o tratamiento de las lesionesde la medula espinal.
ARP990102572A 1998-06-15 1999-05-31 Nuevo uso AR020081A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802119A SE9802119D0 (sv) 1998-06-15 1998-06-15 New use

Publications (1)

Publication Number Publication Date
AR020081A1 true AR020081A1 (es) 2002-04-10

Family

ID=20411702

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102572A AR020081A1 (es) 1998-06-15 1999-05-31 Nuevo uso

Country Status (7)

Country Link
US (1) US6291493B1 (es)
EP (1) EP1094811A1 (es)
JP (1) JP2002518325A (es)
AR (1) AR020081A1 (es)
AU (1) AU4813399A (es)
SE (1) SE9802119D0 (es)
WO (1) WO1999065484A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132103B2 (en) * 2003-08-01 2006-11-07 Enhan Technology Holdings International Co., Ltd. Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900564D0 (sv) 1989-02-17 1989-02-17 Astra Ab Novel medicinal use

Also Published As

Publication number Publication date
JP2002518325A (ja) 2002-06-25
SE9802119D0 (sv) 1998-06-15
US6291493B1 (en) 2001-09-18
EP1094811A1 (en) 2001-05-02
WO1999065484A1 (en) 1999-12-23
AU4813399A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
CO5271715A1 (es) 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
CO4970701A1 (es) Metodo para mantener y/o mejorar la salud de la piel de un usuario en el area cubierta por un articulo absorbente
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2154318T3 (es) Agentes antitromboticos.
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
SE9802208D0 (sv) Novel compounds
AR041339A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
AR041340A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
MY207759A (en) Pharmaceutical drug containing heterocyclidene acetamide derivative
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
TR200200473T2 (tr) Rar selektif retinoid agonistleri.

Legal Events

Date Code Title Description
FB Suspension of granting procedure